ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,64
0,88%
Dow Jones
44 882,13
0,38%
DAX
21 727,20
0,48%
Brent Oil
76,05
0,17%
Bitcoin
105 129,95
1,34%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Neurocrine Biosciences Inc (0K6R) Cours

Neurocrine Biosciences Inc

Neurocrine Biosciences Inc (0K6R)

LSE
91,67
0,00
(0,00%)
Fermé 31 Janvier 5:30PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
91,67
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
1 816
0,00 Fourchette du Jour 0,00
91,67 Plage de 52 semaines 91,67
Cap du marché
9,007B
Clôture Veille
91,67
Ouverture
-
Dernière Transaction
1
@
153.82
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 118
Actions en circulation
98 252 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
60,34
Bénéfice par action (BPA)
2,54
Chiffre d'affairess
1,89B
Bénéfice net
249,7M

À propos de Neurocrine Biosciences Inc

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.neurocrine.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Neurocrine Biosciences Inc est coté dans le secteur Biological Pds,ex Diagnstics de la London Stock Exchange avec le ticker 0K6R. Le dernier cours de clôture d'Neurocrine Biosciences était de US$91,67. Au cours de la dernière année, les actions de Neurocrine Biosciences ont été négociées dans une fourchette de prix de US$ 91,67 à US$ 91,67.

Neurocrine Biosciences compte actuellement 98 252 000 actions en circulation. La capitalisation boursière d'Neurocrine Biosciences est de US$9,01 milliard. Neurocrine Biosciences a un ratio cours/bénéfice (ratio PE) de 60.34.

0K6R Dernières nouvelles

Plus de nouvelles

Diurnal Group PLC EXERCISE OF OPTIONS

Diurnal Group PLC 28 October 2022 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT...

28 Octobre 2022
UK Regulatory

Diurnal Group PLC COURT SANCTION OF SCHEME OF ARRANGEMENT

Diurnal Group PLC 28 October 2022 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT...

28 Octobre 2022
UK Regulatory

Diurnal Group PLC Form 8.3 - IPG - Diurnal Group PLC

Diurnal Group PLC 08 September 2022 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the...

08 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 08 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

08 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 07 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

07 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 06 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

06 Septembre 2022
UK Regulatory

Diurnal Group PLC Form 8 (OPD) (Diurnal Group)

Diurnal Group PLC 05 September 2022 FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code") 1. KEY INFORMATION (a...

05 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 05 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

05 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 02 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

02 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 01 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

01 Septembre 2022
UK Regulatory
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10091.6791.6791.67108091.67DE
40091.6791.6791.67102491.67DE
120091.6791.6791.67111891.67DE
260091.6791.6791.6778291.67DE
520091.6791.6791.6755391.67DE
1560091.6791.6791.67127991.67DE
2600091.6791.6791.6780491.67DE

0K6R - Frequently Asked Questions (FAQ)

What is the current Neurocrine Biosciences share price?
The current share price of Neurocrine Biosciences is US$ 91,67
How many Neurocrine Biosciences shares are in issue?
Neurocrine Biosciences has 98 252 000 shares in issue
What is the market cap of Neurocrine Biosciences?
The market capitalisation of Neurocrine Biosciences is USD 9,01B
What is the 1 year trading range for Neurocrine Biosciences share price?
Neurocrine Biosciences has traded in the range of US$ 91,67 to US$ 91,67 during the past year
What is the PE ratio of Neurocrine Biosciences?
The price to earnings ratio of Neurocrine Biosciences is 60,34
What is the cash to sales ratio of Neurocrine Biosciences?
The cash to sales ratio of Neurocrine Biosciences is 7,98
What is the reporting currency for Neurocrine Biosciences?
Neurocrine Biosciences reports financial results in USD
What is the latest annual turnover for Neurocrine Biosciences?
The latest annual turnover of Neurocrine Biosciences is USD 1,89B
What is the latest annual profit for Neurocrine Biosciences?
The latest annual profit of Neurocrine Biosciences is USD 249,7M
What is the registered address of Neurocrine Biosciences?
The registered address for Neurocrine Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Neurocrine Biosciences website address?
The website address for Neurocrine Biosciences is www.neurocrine.com
Which industry sector does Neurocrine Biosciences operate in?
Neurocrine Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
GILDGuild Esports Plc
0,075p
(66,67%)
158,2M
MSMNMosman Oil And Gas Limited
0,038p
(52,00%)
2,3B
MODER8 Capital Investments Plc
2,10p
(40,00%)
7,75M
LENDSancus Lending Group Limited
0,60p
(33,33%)
2,2M
KMKKromek Group Plc
6,65p
(25,47%)
41,88M
FUMFutura Medical Plc
16,98p
(-45,23%)
8,72M
RCDORicardo Plc
263,00p
(-25,28%)
4,42M
PEGPetards Group Plc
6,50p
(-18,75%)
1,16M
SCGLSealand Capital Galaxy Limited
6,50p
(-14,47%)
6,21M
SIVSivota Plc
3,00p
(-14,29%)
7,5k
MSMNMosman Oil And Gas Limited
0,038p
(52,00%)
2,3B
DKEDukemount Capital Plc
0,055p
(22,22%)
1,4B
EMEEmpyrean Energy Plc
0,115p
(4,55%)
917,03M
TRPTower Resources Plc
0,0295p
(3,51%)
470,89M
DGIDg Innovate Plc
0,0155p
(-8,82%)
344,08M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
0K6R
Neurocrine Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces